FQ3-12136-15894
2 vaccinations
6 coded responses
23 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 856 / AZ
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
- 2020-06-25
-
2021-02-10
Dose 1 — Moderna
-
2021-02-11
Registered in v-safe
-
2021-02-11
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty concentrating. Use of acetomenaphin was not helpfulMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention, Oedema, Swelling — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty concentrating, swelling(edema)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-17
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-25
-
2021-03-10
Dose 2 — Moderna
-
2021-03-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · None · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Swelling and tenderness in armpit area (lymph nodes)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Diarrhea, Abdominal pain · Be unable to workFree text: Swelling of lymph nodes under the armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swelling of lymph nodes under armpit. Some pain in areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-17
Health check-in — day 7, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-31
- 2021-04-09
- 2021-04-14
- 2021-04-21
-
2021-06-11
Survey response — 3 months, dose 2MedDRA: Immune system disorder, Influenza, Nasopharyngitis, Office visit, Rash, Sinusitis, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: My immune system system is weaker since the vaccine. Since March I have had a cold, the flu, upper respiratory infection, sinus infection and moderate-severe rash that has lasted teo weeks (i have a scheduled doctor's appointment for treatment) · Healthcare visit (other): Primary care physician/doctor's officeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-11
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-22
- 2021-09-08
- 2022-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Moderna | |
| 2 | 2021-03-10 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Difficulty concentrating. Use of acetomenaphin was not helpful
Systemic reaction (other): Difficulty concentrating, swelling(edema)
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Swelling and tenderness in armpit area (lymph nodes)
Systemic reaction (other): Swelling of lymph nodes under the arm
Systemic reaction (other): Swelling of lymph nodes under armpit. Some pain in area
Release 9 — 3 months, dose 2
Symptoms: My immune system system is weaker since the vaccine. Since March I have had a cold, the flu, upper respiratory infection, sinus infection and moderate-severe rash that has lasted teo weeks (i have a scheduled doctor's appointment for treatment)
Healthcare visit (other): Primary care physician/doctor's office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Immune system disorder | ✓ | ✓ | ✓ |
| SD | Influenza | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oedema | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release